Table 1.
Characteristics | n | Low | High | High positive rate (%) | P-value | ||
---|---|---|---|---|---|---|---|
(-) | (+) | (++) | (+++) | ||||
FIGO stage | |||||||
I-II | 39 | 1 | 7 | 11 | 20 | 79.49 | 0.673 |
III-IV | 64 | 3 | 8 | 27 | 26 | 82.81 | |
Differentiation | |||||||
Well –moderate | 50 | 3 | 11 | 14 | 22 | 72.00 | 0.015* |
Poor | 53 | 1 | 4 | 24 | 24 | 90.57 | |
LN metastasis | |||||||
No | 75 | 3 | 13 | 24 | 35 | 78.67 | 0.216 |
Yes | 28 | 1 | 2 | 14 | 11 | 89.29 | |
Pathologic type | |||||||
Serous | 48 | 4 | 7 | 22 | 15 | 77.08 | |
Mucinous | 10 | 0 | 0 | 2 | 8 | 100.00 | 0.246 |
Endometrioid | 16 | 0 | 5 | 4 | 7 | 68.75 | |
Clear cell | 11 | 0 | 1 | 3 | 7 | 90.91 | |
Poorly differentiated adenocarcinoma |
18 | 0 | 2 | 7 | 9 | 88.89 |
*P < 0.05.